Carbon-neutral blockchain technology developer Core Scientific raised $54m from Celsius while autoimmune disease therapy developer Topas Therapeutics took a BIVF-backed round past $47m.
Funding Celsius, the developer of a cryptocurrency yield-earning platform, supplied $54m in funding on Tuesday for Core Scientific, a US-based company that provides what it claims is a carbon-neutral blockchain infrastructure. Core Scientific had previously received $1m in equity funding in March 2018, according to a regulatory filing. Germany-based autoimmune disease drug developer Topas Therapeutics…
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.